Using a Nurse-Led Communication Strategy for Surrogates in the Intensive Care Unit
Completed · Not applicable
Conditions studied: Communication Research
In brief
Communication is one of the greatest health needs for high quality end-of-life (EOL) care in the intensive care unit (ICU), especially when patients are too ill to speak for themselves and rely on surrogates to make EOL decisions. Yet, there is no effective nursing intervention designed to improve communication between surrogates and clinicians. In order to enhance understanding of the surrogates' needs in the transition to EOL, this study will propose a new theory-grounded communication intervention, Nurse-Led Communication Strategy (NLCS) and will evaluate its feasibility, acceptability, and preliminary effects.
Key facts
- Study ID
- NCT03770481
- Run by
- State University of New York at Buffalo
- People needed
- 41
- Starts
- 2020-10-01
- Expected to finish
- 2021-02-28
- Last updated by the study team
- 2024-08-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients
- Age ≥ 18 years
- in the ICU for > 24 hours
- Mechanically ventilated within 24 hours of ICU admission
- Having an Acute Physiology and Chronic Health Evaluation (APACHE) IV ICU mortality prediction ≥ 20%
- Surrogates
- Age ≥ 18 years
- A legal New York State healthcare proxy documentation or A Family Health Care Decision Act (FHCDA) consent
You may not qualify if…
- Patients
- Decease or discharge from ICU within 24 hours
- Mechanically ventilated after 24 hours of ICU stay
- Able to communicate and make own decision
- Lack of a legal surrogate/proxy decision-maker to consent for patient participation
- Surrogates
- Lack of legal surrogate documentation
- Not able to complete consent process and questionnaires in English
Where it is running
- Buffalo General Medical Center — Buffalo, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.